Search Results - "BAMBA, Douty"
-
1
A Self-Emulsified Adjuvant System Containing the Immune Potentiator Alpha Tocopherol Induces Higher Neutralizing Antibody Responses than a Squalene-Only Emulsion When Evaluated with a Recombinant Cytomegalovirus (CMV) Pentamer Antigen in Mice
Published in Pharmaceutics (10-01-2023)“…The development of new vaccine adjuvants represents a key approach to improvingi the immune responses to recombinant vaccine antigens. Emulsion adjuvants, such…”
Get full text
Journal Article -
2
The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza
Published in Virology (New York, N.Y.) (10-05-2009)“…Abstract Conventional approaches for therapeutic targeting of viral pathogens have consistently faced obstacles arising from the development of resistant…”
Get full text
Journal Article -
3
Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication
Published in AIDS (London) (02-12-2005)“…To evaluate the effects of the cyclin dependent kinase (CDK) inhibitor Indirubin-3'-monoxime (IM) on Tat-mediated transactivation function, a step of the HIV-1…”
Get full text
Journal Article -
4
Rapamycin Reduces CCR5 Density Levels on CD4 T Cells, and This Effect Results in Potentiation of Enfuvirtide (T-20) against R5 Strains of Human Immunodeficiency Virus Type 1 In Vitro
Published in Antimicrobial Agents and Chemotherapy (01-07-2007)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
5
The Immunomodulatory Agent Rapamycin Potentiates the Antiviral Activity of the Fusion Inhibitor T20 Against R5 Strains of HIV-1
Published in Retrovirology (08-12-2005)Get full text
Journal Article -
6
Antibody targeting of TSG101 on influenza-infected cells
Published in Virus adaptation and treatment (2010)“…Influenza remains a significant cause of morbidity and mortality worldwide. Although vaccination programs and conventional antiviral therapies can reduce…”
Get full text
Journal Article -
7
CCR5 density levels on primary CD4 T cells impact the replication and enfuvirtide susceptibility of R5 HIV-1
Published in AIDS (London) (19-06-2007)“…Studies in cell lines have demonstrated that CCR5 coreceptor levels influence the replication efficiency and Enfuvirtide (T-20) susceptibility of R5 HIV-1…”
Get full text
Journal Article -
8
Rapamycin reduces CCR5 mRNA levels in macaques : potential applications in HIV-1 prevention and treatment
Published in AIDS (London) (01-10-2007)“…G1 cytostatic drugs reduce CCR5 co-receptor expression and enhance the antiviral activity of a CCR5 antagonist in vitro. The administration of rapamycin, a G1…”
Get full text
Journal Article -
9
TSG101 exposure on the surface of HIV-1 infected cells: implications for monoclonal antibody therapy for HIV/AIDS
Published in American journal of translational research (20-07-2010)“…HIV infection remains a major global public health problem, in part because of the ability of the virus to elude antiretroviral therapies. Most conventional…”
Get full text
Journal Article -
10
The Immunomodulatory Agent Rapamycin Potentiates the Antiviral Activity of the Fusion Inhibitor T20 Against R5 Strains of HIV-1
Published in Retrovirology (08-12-2005)Get full text
Journal Article -
11
In vitro suppression of latent HIV-1 activation by vitamin E : potential clinical implications
Published in AIDS (London) (20-05-2005)“…We evaluated the effect of vitamin E in controlling HIV-1 production upon activation of the patients' reservoir of resting CD4 lymphocytes in tissue culture…”
Get full text
Journal Article